Reading the K 10, this company has a bad case of Ebola and bleeding cash and shares of common stock from every available opening and beyond. A few notes not yet serviced so expect there to be quite a bit of dilution coming to the current and future shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.